98%
921
2 minutes
20
Mass spectrometry is used to determine infectious microbial species in thousands of clinical laboratories across the world. The vast amount of data allows modern data analysis methods that harvest more information and potentially answer new questions. Here, we present an end-to-end deep learning model for predicting antibiotic resistance using raw matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) data. We used a 1-dimensional convolutional neural network to model (almost) raw data, skipping conventional peak-picking and directly predict resistance. The model's performance is state-of-the-art, having AUCs between 0.93 and 0.99 in all antimicrobial resistance phenotypes and validates across time and location. Feature attribution values highlight important insights into the model and how the end-to-end workflow can be improved further. This study showcases that reliable resistance phenotyping using MALDI-MS data is attainable and highlights the gains of using end-to-end deep learning for spectrometry data.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824369 | PMC |
http://dx.doi.org/10.1021/acs.analchem.4c05113 | DOI Listing |
IEEE Trans Med Imaging
September 2025
Mammography is a primary method for early screening, and developing deep learning-based computer-aided systems is of great significance. However, current deep learning models typically treat each image as an independent entity for diagnosis, rather than integrating images from multiple views to diagnose the patient. These methods do not fully consider and address the complex interactions between different views, resulting in poor diagnostic performance and interpretability.
View Article and Find Full Text PDFComput Methods Programs Biomed
August 2025
CardioVascular Systems Imaging and Artificial Intelligence Lab, National Heart Centre Singapore, Singapore; Duke-NUS Medical School, Singapore; Department of Biomedical Engineering, National University of Singapore, Singapore. Electronic address:
Background And Objective: To develop an end-to-end artificial intelligence solution-video-based Multi-Point Tracking Network (MPTN), for detecting and tracking atrioventricular junction (AVJ) points from cardiovascular magnetic resonance and deriving AVJ motion parameters.
Methods: The MPTN model consists of two modules: AVJ point detection and AVJ motion tracking. The detection module utilizes convolutional-based feature extraction and elastic regression to detect all candidate AVJ points.
J Am Coll Cardiol
August 2025
Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Cardiology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, California, USA. Electronic address:
Background: Accurate measurement of echocardiographic parameters is crucial for the diagnosis of cardiovascular disease and tracking of change over time; however, manual assessment requires time-consuming effort and can be imprecise. Artificial intelligence has the potential to reduce clinician burden by automating the time-intensive task of comprehensive measurement of echocardiographic parameters.
Objectives: The purpose of this study was to develop and validate open-sourced deep learning semantic segmentation models for the automated measurement of 18 anatomic and Doppler measurements in echocardiography.
Eur J Radiol
September 2025
Department of Radiology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, China. Electronic address:
Background: Homogeneous AI assessment is required for CT-T staging of gastric cancer.
Purpose: To construct an End-to-End CT-based Deep Learning (DL) model for tumor T-staging in advanced gastric cancer.
Materials And Methods: A retrospective study was conducted on 460 cases of presurgical CT patients with advanced gastric cancer between 2011 and 2024.
Int Urol Nephrol
September 2025
Portsmouth Hospitals, University NHS Trust, Portsmouth, UK.
Prostate cancer (PCa) remains one of the most prevalent cancers among men, with over 1.4 million new cases and 375,304 deaths reported globally in 2020. Current diagnostic approaches, such as prostate-specific antigen (PSA) testing and trans-rectal ultrasound (TRUS)-guided biopsies, are often Limited by low specificity and accuracy.
View Article and Find Full Text PDF